Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,252,344 papers from all fields of science
Search
Sign In
Create Free Account
Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder
Known as:
Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorder
This entity represents a spectrum of lymphoproliferative disorders characterized by CD30 (Ki-1)-positive cutaneous T-cell infiltrates. The two ends…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Atypical lymphocyte
Hematopoietic and Lymphoid Cell
Hematopoietic and Lymphoid Tissue
Integumentary system
Expand
Broader (1)
Lymphoma, Primary Cutaneous Anaplastic Large Cell
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
L. McGahan
2019
Corpus ID: 201176033
Several peripheral T-cell lymphomas (PTCL) express the tumour necrosis factor (TNF) receptor CD30, conferring cell survival and…
Expand
2016
2016
A Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Arising in a Patient With Multiple Myeloma and Cutaneous Amyloidosis.
R. Romano
,
D. N. Cohen
,
M. Howard
,
C. Wieland
American journal of dermatopathology
2016
Corpus ID: 25241660
CD30-positive cutaneous lymphoproliferative disorders, a group of T-cell neoplasms, including lymphomatoid papulosis (LyP) and…
Expand
Review
2012
Review
2012
Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma
F. Eberle
,
J. Song
,
+5 authors
E. Jaffe
American Journal of Surgical Pathology
2012
Corpus ID: 20398979
An association between classical Hodgkin lymphoma (cHL) and mycosis fungoides (MF) or lymphomatoid papulosis has been reported in…
Expand
2012
2012
Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.
M. Michai
,
H. Goto
,
+4 authors
S. Okada
Asian Pacific Journal of Cancer Prevention
2012
Corpus ID: 46621523
BACKGROUND The serum level of soluble CD30 (sCD30) is known to be increased with several lymphomas and to correlate with…
Expand
2012
2012
Soluble CD 30 : A Possible Serum Tumor Marker for Primary Effusion Lymphoma
M. Michai
,
H. Goto
,
+4 authors
S. Okada
2012
Corpus ID: 9682551
CD30, a 120 kDa type I surface glycoprotein, is a member of the tumor necrosis factor receptor (TNFR) superfamily, which is…
Expand
2009
2009
Spontaneous regression of primary cutaneous Epstein–Barr virus‐positive, CD30‐positive anaplastic large T‐cell lymphoma in a heart‐transplant recipient
L. S. Chiu
,
P. Choi
,
N. Luk
,
M. Chang
,
W. Tang
Clincal and Experimental Dermatology
2009
Corpus ID: 205277754
We presented a rare case of primary cutaneous Epstein–Barr virus‐positive, CD30‐positive anasplastic large cell lymphoma in a 64…
Expand
Review
2005
Review
2005
Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression
Emiko Takahashi
,
K. Kajimoto
,
T. Fukatsu
,
Megumi Yoshida
,
T. Eimoto
,
S. Nakamura
Virchows Archiv
2005
Corpus ID: 25179177
We reported a case of intravascular T-cell lymphoma (T-IVL) with anaplastic large cell morphology, the hemophagocytic syndrome…
Expand
Review
1994
Review
1994
Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation.
B. Gordon
,
D. Weisenburger
,
W. Sanger
,
J. Armitage
,
P. Coccia
Leukemia and Lymphoma
1994
Corpus ID: 21590968
Although PTCL in children, as in adults, has a spectrum of clinical, morphologic, cytogenetic and immunologic features, there are…
Expand
1994
1994
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.
J. Romaguera
,
J. Manning
,
+6 authors
F. Cabanillas
Annals of Oncology
1994
Corpus ID: 6162012
BACKGROUND We retrospectively assessed the long-term prognostic importance of primary CD30 antigen expression and of anaplastic…
Expand
1993
1993
Therapie maligner kutaner Lymphome
R. Willemze
1993
Corpus ID: 160321013
Die Behandlung maligner Non-Hodgkin-Lymphome richtet sich nach der histologischen Klassifikation und dem klinischen Stadium. In…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE